fixup! Update content/zh-cn/docs/medicine/antiandrogen/medroxyprogesterone/index.md

Co-authored-by: Lee <[email protected]>
Signed-off-by: Mingye Wang <[email protected]>

Author: Artoria2e5

content/zh-cn/docs/medicine/antiandrogen/medroxyprogesterone/index.md

@@ -90,4 +90,4 @@ description: 醋酸甲羟孕酮（Medroxyprogesterone Acetate），是一种类
 [^12]: Meyer W J, Walker P A, Emory L E, et al. Physical, metabolic, and hormonal effects on men of long-term therapy with medroxyprogesterone acetate [J]. *Fertility and Sterility*, 1985, 43(1): 102-109. DOI: [10.1016/S0015-0282(16)48326-3](https://www.sciencedirect.com/science/article/pii/S0015028216483263)
 [^13]: Pfizer. Prescribing Information: PROVERA&reg; [EB/OL]. Drugs@FDA, 2024. <https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/011839s083lbl.pdf> 【[译文](https://tfsci.mtf.wiki/misc/provera/)】
 [^14]: Lynch, M. M., Khandheria, M. M., & Meyer, W. J. (2015). Retrospective Study of the Management of Childhood and Adolescent Gender Identity Disorder Using Medroxyprogesterone Acetate. International Journal of Transgenderism, 16(4), 201–208. https://doi.org/10.1080/15532739.2015.1080649
-[^15]: Wheeler MD, Styne DM. Diagnosis and management of precocious puberty. Pediatr Clin North Am. 1990 Dec;37(6):1255-71. doi: 10.1016/s0031-3955(16)37010-9. PMID: 2147987.
+[^15]: Wheeler MD, Styne DM. Diagnosis and management of precocious puberty. Pediatr Clin North Am. 1990 Dec;37(6):1255-71. doi: [10.1016/s0031-3955(16)37010-9](https://doi.org/10.1016/S0031-3955(16)37010-9). PMID: 2147987.